Status and phase
Conditions
Treatments
About
The purpose of this study is to determine the bioavailability of 0.5% ivermectin cream in a pediatric population aged 6 months to 3 years.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Subject must be 6 months to 3 years of age, inclusive, when informed consent is signed.
Subject must be infested with head lice as demonstrated by the presence of at least 1 live louse prior to treatment.
Subject is in general good health.
Subject's parent/guardian (caregiver) must be willing and able to bring subject to all study visits as scheduled.
Subject's caregiver must have provided written informed consent (assent is not required due to the young age of the subjects).
Subject's caregiver must agree to comply with the following study restrictions:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
30 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal